retatrutide latest clinical trial results news ⭐️topline results from TRIUMPH-1, a Phase 3 trial evaluating # Retatrutide FDA Approval Status 2026:

Weight loss medications can be powerful tools in improving overall health

Discussion In this study, we aimed to understand if people with T2D, who were newly prescribed GLP-1 RAs labeled for T2D, were initiating treatment at markers indicative of lower disease severity

34 GLP-1RAs exhibit anti-inflammatory capabilities that go beyond their function in glucose management

SHAWN STEVENSON: Oh wow

However, no benefits on mortality or CVD events were noted with intensive lifestyle modification

As CYP8B1 acts to catalyze 12-hydroxylation and is required for CA synthesis, it serves as a master regulator for the BA composition